- Home
- ELEV vs FEMY Comparison
ELEV vs FEMY Comparison
Compare ELEV & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- FEMY
- Stock Information
- Founded
- ELEV 2019
- FEMY 2004
- Country
- ELEV United States
- FEMY United States
- Employees
- ELEV N/A
- FEMY N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- ELEV Health Care
- FEMY Health Care
- Exchange
- ELEV Nasdaq
- FEMY Nasdaq
- Market Cap
- ELEV 37.6M
- FEMY N/A
- IPO Year
- ELEV 2021
- FEMY 2021
- Fundamental
- Price
- ELEV $0.26
- FEMY $1.29
- Analyst Decision
- ELEV Buy
- FEMY Strong Buy
- Analyst Count
- ELEV 7
- FEMY 2
- Target Price
- ELEV $3.78
- FEMY $11.50
- AVG Volume (30 Days)
- ELEV 2.1M
- FEMY 601.9K
- Earning Date
- ELEV 03-06-2025
- FEMY 03-27-2025
- Dividend Yield
- ELEV N/A
- FEMY N/A
- EPS Growth
- ELEV N/A
- FEMY N/A
- EPS
- ELEV N/A
- FEMY N/A
- Revenue
- ELEV N/A
- FEMY $1,629,108.00
- Revenue This Year
- ELEV N/A
- FEMY $550.60
- Revenue Next Year
- ELEV N/A
- FEMY $76.32
- P/E Ratio
- ELEV N/A
- FEMY N/A
- Revenue Growth
- ELEV N/A
- FEMY 51.97
- 52 Week Low
- ELEV $0.24
- FEMY $0.86
- 52 Week High
- ELEV $5.83
- FEMY $1.84
- Technical
- Relative Strength Index (RSI)
- ELEV 23.65
- FEMY 37.64
- Support Level
- ELEV $0.24
- FEMY $1.25
- Resistance Level
- ELEV $0.55
- FEMY $1.63
- Average True Range (ATR)
- ELEV 0.04
- FEMY 0.17
- MACD
- ELEV -0.02
- FEMY -0.03
- Stochastic Oscillator
- ELEV 6.23
- FEMY 7.84
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.